Baseline blood immunological profiling differentiates between Her2–breast cancer molecular subtypes: implications for immunomediated mechanisms of treatment response

PURPOSE: Breast cancer patients’ response to treatment is highly dependent on the primary tumor molecular features, with triple-negative breast tumors having the worst prognosis of all subtypes. According to the molecular features, tumors stimulate the microenvironment to induce distinct immune resp...

Descripción completa

Detalles Bibliográficos
Autores principales: Tudoran, Oana, Virtic, Oana, Balacescu, Loredana, Lisencu, Carmen, Fetica, Bogdan, Gherman, Claudia, Balacescu, Ovidiu, Berindan-Neagoe, Ioana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4655955/
https://www.ncbi.nlm.nih.gov/pubmed/26604799
http://dx.doi.org/10.2147/OTT.S91720

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4655955/
https://www.ncbi.nlm.nih.gov/pubmed/26604799
http://dx.doi.org/10.2147/OTT.S91720

Ejemplares similares